Adverse Event Reporting

VAERS ID 965209
Gender Male
Age 62
StateCode
Pharmaceutical Company PFIZER\BIONTECH
Lot Number
Number of vaccinations
Vaccinated 2021-01-11
Onset 2021-01-14
Condition Hospitalized Life Threatening Permanent Disability Recovered
Symptoms
  • Acute myocardial infarction
  • Echocardiogram abnormal
  • Coronary artery occlusion
  • Ejection fraction decreased
  • Ventricular hypokinesia
  • Coronary arterial stent insertion
  • Coronary artery stenosis
  • Percutaneous coronary intervention
  • Wall motion score index abnormal

Current Illness

None noted

Preexisting Conditions

Hypertension, prediabetes

Other Medications

Candesartan 4mg daily

Previous Vaccinations

Allergies

None

Laboratory Data

PCI on 1/14.
Acute subtotal occlusion of proximal LAD and severe diffuse disease extending to distal LAD.
Two DES to LAD (99% occluded) but RCA 50% and OMI1 60-65% also stenosed.
Echo cardiogram 1/15.
Pt noted to have severe wall motion abnormalities (severe hypokinesis of anterolateral and anteroseptal wall; akinesis of mid to distal anterior wall extending to the apex and distal inferior wall ) on echo.
EF 30-35%.
Received life vest on discharge.

Write-up

Pt admitted with a STEMI three days after vaccination with pzifer COVID-19 vaccine.
Short time (<2hr) between symptoms onset and medical care.
PCI on 1/14.
Acute subtotal occlusion of proximal LAD and severe diffuse disease extending to distal LAD.
Two DES to LAD (99% occluded) but RCA 50% and OMI1 60-65% also stenosed.
Echo cardiogram 1/15.
Pt noted to have severe wall motion abnormalities (severe hypokinesis of anterolateral and anteroseptal wall; akinesis of mid to distal anterior wall extending to the apex and distal inferior wall ) on echo.
EF 30-35%.
Received life vest on discharge.